SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-084515
Filing Date
2023-03-30
Accepted
2023-03-30 07:37:04
Documents
13
Period of Report
2023-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d477933d8k.htm   iXBRL 8-K 26273
  Complete submission text file 0001193125-23-084515.txt   190273

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA xoma-20230329.xsd EX-101.SCH 3868
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20230329_def.xml EX-101.DEF 14109
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20230329_lab.xml EX-101.LAB 23493
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20230329_pre.xml EX-101.PRE 15142
7 EXTRACTED XBRL INSTANCE DOCUMENT d477933d8k_htm.xml XML 6649
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 23777164
SIC: 2834 Pharmaceutical Preparations